|
⚲
|
| Keyboard |
| John Siebert | |
|---|---|
| Firm | |
| Address | 3929 Point Eden Way Hayward, CA 94545 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Aradigm Corp | 021-262513 | Director | 23.0 M of 23.0 M |
||
| Chase Pharmaceuticals Corp | 021-246193 | Executive Officer | 3.5 M of 3.5 M |
||
| Accu-Break Pharmaceuticals Inc | 021-240947 | Director | 0.5 M of 1.0 M |
||
| Chase Pharmaceuticals Corp | 021-218283 | Executive Officer | 6.1 M of 8.6 M |
||
| Accu-Break Pharmaceuticals Inc | 021-196738 | Director | 1.0 M of 1.5 M |
||
| Supernus Pharmaceuticals Inc | 021-154736 | Director | 30.0 M of 30.0 M |
||
| Aradigm Corp | 021-144161 | Director | 4.1 M of 4.1 M |
||